"At Myovant, we know that stigma can often keep people quiet about periods, leading to delayed care and increased discomfort. It also contributes to the lack of awareness about how conditions such as endometriosis and uterine fibroids can increase absenteeism and impact performance at work and school," said Kalahn Taylor-Clark, Vice President and Head of Strategic Partnerships and Innovation at Myovant Sciences. "As a company focused on women's health conditions, we hope these survey results will encourage employers to recognise and better understand the issue and work to create an environment that improves workplace equity."